Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
ACCF/ASNC/ACR/
AHA/ASE/SCCT/
SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging
SCIENCE ADVISORY: Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:1214-1223, doi:10.1016/j.jacc.2006.01.049 (Published online 8 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.01.049v1
47/6/1214    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (96)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cribier, A.
Right arrow Articles by Babaliaros, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cribier, A.
Right arrow Articles by Babaliaros, V.

EXPEDITED REVIEW

Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve

Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience

Alain Cribier, MD, FACC*,*, Helene Eltchaninoff, MD*, Christophe Tron, MD*, Fabrice Bauer, MD*, Carla Agatiello, MD*, Deborah Nercolini, MD*, Sydney Tapiero, MD*, Pierre-Yves Litzler, MD{dagger}, Jean-Paul Bessou, MD{dagger} and Vasilis Babaliaros, MD*

* Department of Cardiology, Charles Nicolle Hospital, Rouen, France
{dagger} Department of Cardiac Surgery, Charles Nicolle Hospital, Rouen, France

Manuscript received December 20, 2005; revised manuscript received January 19, 2006, accepted January 24, 2006.

* Reprint requests and correspondence: Dr. Alain Cribier, Service de Cardiologie, Hopital Charles Nicolle, 1 rue de Germont, 76 031 Rouen Cedex, France (Email: Alain.Cribier{at}chu-rouen.fr).

OBJECTIVES: The aim of this work was to study the feasibility, safety, efficacy, and durability of percutaneous heart valve (PHV) implantation in the aortic position.

BACKGROUND: We developed a PHV (equine pericardium valve in a balloon-expandable, stainless-steel stent) to treat patients with inoperable aortic stenosis (AS).

METHODS: Thirty-six patients (aortic valve area ≤0.7 cm2, New York Heart Association [NYHA] functional class IV, and severe comorbidities), formally declined for surgery, were recruited on a compassionate basis. The PHV was implanted by retrograde or antegrade trans-septal approach. Clinical and echocardiographic outcomes were assessed serially.

RESULTS: Twenty-seven patients were implanted successfully (23 antegrade, 4 retrograde) in the subcoronary position with improvement in valve area (0.60 ± 0.11 cm2 to 1.70 ± 0.10 cm2, p < 0.0001) and transvalvular gradient (37 ± 13 mm Hg to 9 ± 2 mm Hg, p < 0.0001). Paravalvular aortic regurgitation was grade 0 to 1 (n = 10), grade 2 (n = 12), and grade 3 (n = 5). One week post-procedure, improvement in left ventricular function (45 ± 18% to 53 ± 14%, p = 0.02) was most pronounced in patients with ejection fraction <50% (35 ± 10% to 50 ± 16%, p < 0.0001). Thirty-day major adverse events after successful implantation were 26% (pericardial tamponade, stroke, arrhythmia, urosepsis, and one death unexplained at autopsy). Eleven patients are currently alive with follow-up of 9 months (n = 2), 10 months (n = 3), 11 months (n = 1), 12 months (n = 2), 23 months (n = 1), and 26 months (n = 2). All patients experienced amelioration of symptoms (>90% NYHA functional class I to II). Percutaneous heart valve function remained unchanged during follow-up, and no deaths were device-related.

CONCLUSIONS: Percutaneous heart valve implantation is feasible in inoperable patients with end-stage AS leading to hemodynamic and clinical improvement. Continued advances and improved patient selection should decrease adverse events in the near future.

Abbreviations and Acronyms
  AVA = aortic valve area
  BAV = balloon aortic valvuloplasty
  I-REVIVE = Initial Registry of EndoVascular Implantation of Valves in Europe trial
  MACCE = major adverse cardiac and cerebrovascular events
  MI = myocardial infarction
  NYHA = New York Heart Association
  PHV = percutaneous heart valve
  RECAST = Registry of Endovascular Critical Aortic Stenosis Treatment trial
  TTE = transthoracic echocardiography




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
F. Aregger, P. Wenaweser, G. J. Hellige, A. Kadner, T. Carrel, S. Windecker, and F. J. Frey
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2175 - 2179.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Al-Attar, D. Himbert, F. Descoutures, B. Iung, R. Raffoul, D. Messika-Zeitoun, E. Brochet, F. Francis, H. Ibrahim, A. Vahanian, et al.
Transcatheter Aortic Valve Implantation: Selection Strategy Is Crucial for Outcome.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1757 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. R. Kapadia, S. S. Goel, L. Svensson, E. Roselli, R. M. Savage, L. Wallace, S. Sola, P. Schoenhagen, M. H. Shishehbor, R. Christofferson, et al.
Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1430 - 1435.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Zajarias and A. G. Cribier
Outcomes and Safety of Percutaneous Aortic Valve Replacement
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1829 - 1836.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M.-A. Clavel, J. G. Webb, P. Pibarot, L. Altwegg, E. Dumont, C. Thompson, R. De Larochelliere, D. Doyle, J.-B. Masson, S. Bergeron, et al.
Comparison of the Hemodynamic Performance of Percutaneous and Surgical Bioprostheses for the Treatment of Severe Aortic Stenosis
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1883 - 1891.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
F. T. Billings IV, S. K. Kodali, and J. S. Shanewise
Transcatheter Aortic Valve Implantation: Anesthetic Considerations
Anesth. Analg., May 1, 2009; 108(5): 1453 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 Crit Care NurseHome page
M. E. McRae, M. Rodger, and B. A. Bailey
Transcatheter and Transapical Aortic Valve Replacement
Crit. Care Nurse, February 1, 2009; 29(1): 22 - 36.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Piazza, Y. Onuma, P. de Jaegere, and P. W. Serruys
Guidelines for reporting mortality and morbidity after cardiac valve interventions--need for a reappraisal?
Ann. Thorac. Surg., February 1, 2009; 87(2): 357 - 358.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M.-A. Clavel, E. Dumont, P. Pibarot, D. Doyle, R. De Larochelliere, J. Villeneuve, S. Bergeron, C. Couture, and J. Rodes-Cabau
Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation.
Ann. Thorac. Surg., February 1, 2009; 87(2): 618 - 621.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
R D Christofferson, S R Kapadia, V Rajagopal, and E M Tuzcu
Emerging transcatheter therapies for aortic and mitral disease
Heart, January 15, 2009; 95(2): 148 - 155.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Ye, A. Cheung, S. V. Lichtenstein, L. A. Altwegg, D. R. Wong, R. G. Carere, C. R. Thompson, R. R. Moss, B. Munt, S. Pasupati, et al.
Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients.
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EchocardiogrHome page
D. Chin
Echocardiography for transcatheter aortic valve implantation
Eur J Echocardiogr, January 1, 2009; 10(1): i21 - i29.
[Abstract] [Full Text] [PDF]

Home page
 Cleveland Clinic Journal of MedicineHome page
I. M. SINGH, E. M. TUZCU, M. H. SHISHEHBOR, S. R. KAPADIA, and R. D. CHRISTOFFERSON
Percutaneous treatment of aortic valve stenosis
Cleveland Clinic Journal of Medicine, November 1, 2008; 75(11): 805 - 812.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss
The transapical approach for aortic valve implantation.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 948 - 953.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
V. C. Babaliaros, D. Liff, E. P. Chen, J. H. Rogers, R. A. Brown, V. H. Thourani, R. A. Guyton, S. Lerakis, A. E. Stillman, P. Raggi, et al.
Can Balloon Aortic Valvuloplasty Help Determine Appropriate Transcatheter Aortic Valve Size?
J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 580 - 586.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc InterventHome page
J. Schofer, M. Schluter, H. Treede, O. W. Franzen, T. Tubler, A. Pascotto, R. I. Low, S. F. Bolling, T. Meinertz, and H. Reichenspurner
Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High-Surgical-Risk Patients With Severe Aortic Stenosis: A First-in-Man Feasibility and Safety Study
Circ Cardiovasc Intervent, October 1, 2008; 1(2): 126 - 133.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P.-Y. Litzler, A. Cribier, A. Zajarias, D. Comte, H. Eltchaninoff, C. Tron, C. Haas-Hubscher, and J.-P. Bessou
Surgical aortic valve replacement after percutaneous aortic valve implantation: What have we learned?
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 697 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc InterventHome page
N. Piazza, P. de Jaegere, C. Schultz, A. E. Becker, P. W. Serruys, and R. H. Anderson
Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve
Circ Cardiovasc Intervent, August 1, 2008; 1(1): 74 - 81.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
P. T.L. Chiam and C. E. Ruiz
Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials: The Interventionalist Perspective
J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 341 - 350.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Vahanian, O. R. Alfieri, N. Al-Attar, M. J. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
T. Walther, V. Falk, J. Kempfert, M. A. Borger, J. Fassl, M. W.A. Chu, G. Schuler, and F. W. Mohr
Transapical minimally invasive aortic valve implantation; the initial 50 patients
Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 983 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F. Descoutures, D. Himbert, L. Lepage, B. Iung, D. Detaint, D. Tchetche, E. Brochet, Y. Castier, J.-P. Depoix, P. Nataf, et al.
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly
Eur. Heart J., June 1, 2008; 29(11): 1410 - 1417.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. J. Antunes
Percutaneous aortic valve implantation. The demise of classical aortic valve replacement?
Eur. Heart J., June 1, 2008; 29(11): 1339 - 1341.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur. Heart J., June 1, 2008; 29(11): 1463 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
N. Piazza, Y. Onuma, E. Jesserun, P. P. Kint, A.-M. Maugenest, R. H. Anderson, P. P. T. de Jaegere, and P. W. Serruys
Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 310 - 316.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
L. F. Tops, D. A. Wood, V. Delgado, J. D. Schuijf, J. R. Mayo, S. Pasupati, F. P.L. Lamers, E. E. van der Wall, M. J. Schalij, J. G. Webb, et al.
Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement.
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R. Ramaraj and V. L Sorrell
Degenerative aortic stenosis
BMJ, March 8, 2008; 336(7643): 550 - 555.
[Full Text] [PDF]

Home page
 CirculationHome page
J. F. Rhodes, Z. M. Hijazi, and R. J. Sommer
Pathophysiology of Congenital Heart Disease in the Adult, Part II: Simple Obstructive Lesions
Circulation, March 4, 2008; 117(9): 1228 - 1237.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. Murtuza, J. R. Pepper, R. DeL Stanbridge, C. Jones, C. Rao, A. Darzi, and T. Athanasiou
Minimal Access Aortic Valve Replacement: Is It Worth It?
Ann. Thorac. Surg., March 1, 2008; 85(3): 1121 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Zegdi, G. Sleilaty, A. Lafont, and J.-N. Fabiani
Percutaneous Aortic Valve Replacement With the CoreValve Prosthesis
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 170 - 170.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. A. Grossi, C. F. Schwartz, P.-J. Yu, U. P. Jorde, G. A. Crooke, J. B. Grau, G. H. Ribakove, F. G. Baumann, P. Ursumanno, A. T. Culliford, et al.
High-Risk Aortic Valve Replacement: Are the Outcomes as Bad as Predicted?
Ann. Thorac. Surg., January 1, 2008; 85(1): 102 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
R. F. Padera Jr. and F. J. Schoen
Pathology of Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178.
[Full Text]

Home page
 Card Surg AdultHome page
N. D. Desai and G. T. Christakis
Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves
Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894.
[Full Text]

Home page
 Card Surg AdultHome page
M. J. Davidson and D. S. Baim
Percutaneous Aortic Valve Interventions
Card. Surg. Adult, January 1, 2008; 3(2008): 963 - 971.
[Full Text]

Home page
 CirculationHome page
T. Feldman and M. B. Leon
Prospects for Percutaneous Valve Therapies
Circulation, December 11, 2007; 116(24): 2866 - 2877.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. Grube, G. Schuler, L. Buellesfeld, U. Gerckens, A. Linke, P. Wenaweser, B. Sauren, F.-W. Mohr, T. Walther, B. Zickmann, et al.
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis: Device Success and 30-Day Clinical Outcome
J. Am. Coll. Cardiol., July 3, 2007; 50(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Tabata, Z. Khalpey, S. F. Aranki, G. S. Couper, L. H. Cohn, and P. S. Shekar
Minimal Access Surgery of Ascending and Proximal Arch of the Aorta: A 9-Year Experience
Ann. Thorac. Surg., July 1, 2007; 84(1): 67 - 72.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. Bergler-Klein, G. Mundigler, P. Pibarot, I. G. Burwash, J. G. Dumesnil, C. Blais, C. Fuchs, D. Mohty, R. S. Beanlands, Z. Hachicha, et al.
B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study
Circulation, June 5, 2007; 115(22): 2848 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L. Coats and P. Bonhoeffer
NEW PERCUTANEOUS TREATMENTS FOR VALVE DISEASE
Heart, May 1, 2007; 93(5): 639 - 644.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 509 - 527.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J., January 26, 2007; (2007) ehl428v1.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. Ye, A. Cheung, S. V. Lichtenstein, S. Pasupati, R. G. Carere, C. R. Thompson, A. Sinhal, and J. G. Webb
Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 16 - 21.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. Grube, J. C. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann, et al.
Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study
Circulation, October 10, 2006; 114(15): 1616 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. V. Lichtenstein, A. Cheung, J. Ye, C. R. Thompson, R. G. Carere, S. Pasupati, and J. G. Webb
Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience
Circulation, August 8, 2006; 114(6): 591 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Journal Watch CardiologyHome page
Percutaneous Aortic Valve Implantation: Mid-Term Follow-Up
Journal Watch Cardiology, May 11, 2006; 2006(511): 2 - 2.
[Full Text]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement